BC Week In Review | Jun 9, 2014
Clinical News

DCVAC/PCa: Phase III started

Sotio a.s. , Prague, Czech Republic   Product: DCVAC/PCa   Business: Cancer   Molecular target: NA   Description: Active cellular immunotherapy for prostate cancer that uses a patient's dendritic cells to induce an immune reaction against...
Items per page:
1 - 1 of 1